Acute pain
Conditions
Interventions
This is a clinical, prospective, randomized, interventionist, partially blinded study because it is an intervention guided by the nociception level monitor (NOL) in patients of both sexes, submitted t
Sponsors
Fundação do ABC
Fundação do ABC
Eligibility
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Adult men and women will be included; aged between 18 and 65 years; diagnosed with obesity who will undergo gastroplasty by videolaparoscopy' who agree to participate in the research after signing the free and informed consent form
Exclusion criteria
Exclusion criteria: Any patient who does not agree to participate in the study; ASA 3 or 4; previous use of opioids or illicit drugs; has a diagnosis of chronic pain; oncological diseases; history of cognitive psychiatric renal or neurological disorders; contraindication or allergy to any drug to be used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate whether the use of the nociception monitor (NOL) changes the amount of the opioid analgesic remifentanil administered intraoperatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate whether the use of NOL during surgery changes the consumption of morphine and non-opioid analgesics in the first 48 hours after the end of surgery.;Evaluate whether the use of NOL during surgery changes the incidence of adverse events, such as intraoperative hypotension, nausea and vomiting in the first 48 hours after the end of surgery. ;To assess whether NOL use during surgery alters the time to the first rescue analgesic request after the end of surgery. | — |
Countries
Brazil
Contacts
Public ContactGeorgiana Freire
Fundação do ABC
Outcome results
None listed